Adrenomedullin: a vasodilator to treat sepsis?

Adrenomedullin: a vasodilator to treat sepsis?

Adrenomedullin is a vasodilatory polypeptide with pleiotropic effects secreted by various organs. Adrenomedullin is produced first as a prepropeptide, and then cleaved into mature adrenomedullin and mid-regional proadrenomedullin. Whereas levels of the latter have been shown to correlate with severity of sepsis and carry prognostic value, adrenomedullin plays a role in vascular tone homeostasis...

Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis.

Adrenomedullin (AM), a potent vasodilatory peptide, plays an important role in initiating the hyperdynamic response during the early stage of sepsis. Moreover, the reduced vascular responsiveness to AM appears to be responsible for the transition from the early, hyperdynamic to the late, hypodynamic phase of sepsis. Although the novel specific AM binding protein-1 (AMBP-1) enhances AM-mediated ...

Strategies to treat sepsis : old and new

ISSN 2041-6792 10.4155/CLI.10.19 © 2011 Future Science Ltd Despite advances in critical care, the incidence and mortality from severe sepsis remains unacceptably high. Numerous strategies focusing on the pathophysiology of severe sepsis are being pursued. Bacteria and bacterial products that trigger sepsis are being targeted via antibodies, signaling antagonists and filtration columns. Excessiv...

Adrenomedullin Binding Protein-1 Modulates Vascular Responsiveness to Adrenomedullin During the Late Stage of Sepsis

Immunological monitoring to prevent and treat sepsis

The clinical, human and economic burden associated with sepsis is huge. Initiatives such as the Surviving Sepsis Campaign aim to effectively reduce risk of death from severe sepsis and septic shock. Nonetheless, although substantial benefits raised from the implementation of this campaign have been obtained, much work remains if we are to realise the full potential promised by this strategy. A ...